Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Prostatic Neoplasms 14Lymphoma, Follicular 6Neoplasm Metastasis 5Lymphoma, Large B-Cell, Diffuse 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell 3Hemangioma 3Neoplasms 2Urogenital Neoplasms 1Thymoma 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Myasthenia Gravis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, T-Cell 1Leukemia, Lymphoid 1Leukemia, Biphenotypic, Acute 1Leukemia 1Hodgkin Disease 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

fludarabine phosphate 23Cyclophosphamide 23Whole-Body Irradiation 20Mycophenolic Acid 17Peripheral Blood Stem Cell Transplantation 15Busulfan 14Cyclosporine 12Tacrolimus 10Melphalan 10Antilymphocyte Serum 9Cord Blood Stem Cell Transplantation 7Rituximab 6Radiotherapy 6Methotrexate 6Filgrastim 6Etoposide 6fludarabine 5Methylprednisolone 5Granulocyte Colony-Stimulating Factor 4Vincristine 3Thiotepa 3Sirolimus 3Prednisone 3Methylprednisolone Hemisuccinate 3Methylprednisolone Acetate 3Doxorubicin 3Cytarabine 3Carboplatin 3Alemtuzumab 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Dendritic Cell Sarcoma, Interdigitating × Prednisolone × Clear all
NCT03003520 2023-05-22

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

Celgene

Phase 2 Completed
46 enrolled 20 charts
LymphoidSarcoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡